Macroautophagy—a novel β-amyloid peptide-generating pathway activated in Alzheimer's disease
Open accessThe DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Abstract
Macroautophagy, which is a lysosomal pathway for the turnover of organelles and long-lived proteins, is a key determinant of cell survival and longevity. In this study, we show that neuronal macroautophagy is induced early in Alzheimer's disease (AD) and before β-amyloid (Aβ) deposits extracellularly in the presenilin (PS) 1/Aβ precursor protein (APP) mouse model of β-amyloidosis. Subsequently, autophagosomes and late autophagic vacuoles (AVs) accumulate markedly in dystrophic dendrites, implying an impaired maturation of AVs to lysosomes. Immunolabeling identifies AVs in the brain as a major reservoir of intracellular Aβ. Purified AVs contain APP and β-cleaved APP and are highly enriched in PS1, nicastrin, and PS-dependent γ-secretase activity. Inducing or inhibiting macroautophagy in neuronal and nonneuronal cells by modulating mammalian target of rapamycin kinase elicits parallel changes in AV proliferation and Aβ production. Our results, therefore, link β-amyloidogenic and cell survival pathways through macroautophagy, which is activated and is abnormal in AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, the abundant accumulation of autophagic vacuoles in swollen (malnourished) neurons is observed to have a linkage with Aβ/APP-βCTF, suggesting that autophagy clearance is severely disrupted under pathological conditions and is closely linked to amyloid pathology.115,225,230”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [230]
Experimental — accuracy not yet measuredIn the citing paper
“Autophagosomes contain APP, presenilin and γ-secretase, and disruption of autophagosome processing in neurons can lead to increased production of Aβ77, which can in turn further inhibit protein digestion78,79.”
From Tau-targeting therapies for Alzheimer disease (2018) · cites this paper as [77]
In the citing paper
“deficits in autophagy have been implicated in multiple neurodegenerative diseases [18–21]”
In the citing paper
“While neurons such as RGCs depend highly on autophagy, deficits in autophagy have been implicated in multiple neurodegenerative diseases [18–21]”
In the citing paper
“These abnormal, swollen neurites were invariably near plaques and appeared analogous to those observed in other AD mouse models [8, 23, 56, 67, 76, 89, 119] as well as human AD brains [45, 66, 72, 92, 100].”
From The Alzheimer’s β-secretase BACE1 localizes to normal presynaptic terminals and to dystrophic presynaptic terminals surrounding amyloid plaques (2013) · cites this paper as [119]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Two new Later Stone Age sites from the Final Pleistocene in the Falémé Valley, eastern Senegal
Ndiaye, M., Lespez, L., Tribolo, C., Rassé, M., Hadjas, I., Davidoux, S., Huysecom, É., & Douze, K. (2024) · Monash University Research Portal (Monash University) · doi:10.3929/ethz-b-000667478 · Cited by 23,868
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 4×
“, 1999), Braak staging (Braak and Braak, 1991), and the criteria proposed by Mirra et al.”
BackgroundMethodInfluentialLC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing.
Kabeya, Y., Mizushima, N., Ueno, T., Yamamoto, A., Kirisako, T., Noda, T., Kominami, E., Ohsumi, Y., & Yoshimori, T. (2000) · The EMBO Journal · doi:10.1093/emboj/19.21.5720 · Cited by 6,605 · cited 1×
“A pAb to LC3 was made that recognized native (LC3-I) and postautophagic-induced JCB • VOLUME 171 • NUMBER 1 • 200596 protein (LC3-II; Kabeya et al., 2000, 2004; Mizushima et al., 2004).”
BackgroundCui, C., Cui, J., Jin, F., Cui, Y., Li, R., Jiang, X., Tian, Y., Wang, K., Jiang, P., & Gao, J. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479571 · Cited by 5,203
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961 · cited 2×
“Seven of these cases (aged 71–86 yr) were later found to meet the neuropathological criteria of AD (Braak and Braak, 1991; Mirra et al., 1991, 1993; Newell et al., 1999), and the remaining three specimens (aged 67–72 yr) were found to be neuropathologically normal (Wegiel et al., 2000).”
BackgroundMethodConsortium to Establish a Registry for Alzheimer's Disease (CERAD)
Fillenbaum, G. G., & Heyman, A. (2002) · Principles and Practice of Geriatric Psychiatry · doi:10.1002/0470846410.ch42(iii · Cited by 2,410
Ravikumar, B., Vacher, C., Berger, Z., Davies, J. E., Luo, S., Oroz, L. G., Scaravilli, F., Easton, D. F., Duden, R., O'Kane, C. J., et al. (2004) · Nature Genetics · doi:10.1038/ng1362 · Cited by 2,347 · cited 3×
“Moreover, macroautophagy is involved in degrading mutated and aggregated proteins that are implicated in neurodegenerative diseases, including Parkinson’s (Cuervo et al., 2004) and Huntington’s disease (Ravikumar et al., 2004).”
BackgroundInfluentialMizushima, N., Yamamoto, A., Matsui, M., Yoshimori, T., & Ohsumi, Y. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-09-0704 · Cited by 2,105 · cited 3×
“LC3-II, a phosphatidylethanolamine-modified isoform of the microtubule-associated protein LC3-I, is generated and translocated to nascent autophagosomes when macroautophagy is induced, and its presence, therefore, is a putative index of macroautophagy induction (Mizushima et al., 2004).”
BackgroundImpaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy
Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T., & Sulzer, D. (2004) · Science · doi:10.1126/science.1101738 · Cited by 2,024 · cited 2×
“Moreover, macroautophagy is involved in degrading mutated and aggregated proteins that are implicated in neurodegenerative diseases, including Parkinson’s (Cuervo et al., 2004) and Huntington’s disease (Ravikumar et al., 2004).”
BackgroundInfluentialSelf-citationDevelopmental cell death: morphological diversity and multiple mechanisms
Clarke, P. H. (1990) · Anatomy and Embryology · doi:10.1007/bf00174615 · Cited by 1,695 · cited 2×
“Although macroautophagy appears to be neuroprotective in these settings, sustained overactivity during embryonic development (Clarke, 1990), response to ER stress, exposure to toxins (Kanzawa et al., 2004), or dysfunction of the autophagic pathway in pathological states mediate a…”
BackgroundInhibition of Macroautophagy Triggers Apoptosis
Boya, P., González-Polo, R.-A., Casares, N., Perfettini, J.-L., Dessen, P., Larochette, N., Métivier, D., Meley, D., Souquere, S., Yoshimori, T., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.3.1025-1040.2005 · Cited by 1,625 · cited 2×
“Macroautophagy may protect cells from apoptosis (Boya et al., 2005), probably by eliminating damaged mitochondria (Brunk and Terman, 2002), and is reCorrespondence to Ralph A.”
BackgroundExtensive Involvement of Autophagy in Alzheimer Disease: An Immuno-Electron Microscopy Study
Nixon, R. A., Wegiel, J., Kumar, A., Yu, W. H., Peterhoff, C., Cataldo, A., & Cuervo, A. M. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.2.113 · Cited by 1,588 · cited 12×
“In dystrophic neurites, however, the striking buildup of autophagosomes and late AVs implies a defect in AV transport, maturation to lysosomes, or both, which is likely to impede lysosomal degradation through this pathway (Nixon et al., 2005).”
BackgroundMethodInfluentialSelf-citationIncreased amyloid-β42(43) in brains of mice expressing mutant presenilin 1
Duff, K., Eckman, C., Zehr, C., Yu, X., Prada, C.-M., Perez-tur, J., Hutton, M., Buee, L., Harigaya, Y., Yager, D., et al. (1996) · Nature · doi:10.1038/383710a0 · Cited by 1,465 · cited 2×
“Transgenic mice expressing the Swedish mutation of human APP (APPK670M/N671L) and mutant human PS1 (PS1M146L; Duff et al., 1996) were studied at 8–9 wk, 9 mo, and 18–22 mo of age together with age-matched controls.”
BackgroundSelf-citationLC3, GABARAP and GATE16 localize to autophagosomal membrane depending on form-II formation
Kabeya, Y., Mizushima, N., Yamamoto, A., Oshitani-Okamoto, S., Ohsumi, Y., & Yoshimori, T. (2004) · Journal of Cell Science · doi:10.1242/jcs.01131 · Cited by 1,394 · cited 1×
“A pAb to LC3 was made that recognized native (LC3-I) and postautophagic-induced JCB • VOLUME 171 • NUMBER 1 • 200596 protein (LC3-II; Kabeya et al., 2000, 2004; Mizushima et al., 2004).”
BackgroundHolcomb, L., Gordon, M. N., McGowan, E., Yu, X., Benkovic, S., Jantzen, P., Wright, K., Saad, I., Mueller, R., Morgan, D., et al. (1998) · Nature Medicine · doi:10.1038/nm0198-097 · Cited by 1,386 · cited 4×
“PS1/APP mice begin to deposit A after 10 wk of age and progressively develop many neuritic plaques that mainly consist of A and grossly swollen dendrites and axons (Holcomb et al., 1998).”
BackgroundInfluentialSelf-citationAutophagy as a cell death and tumor suppressor mechanism
Gozuacik, D., & Kimchi, A. (2004) · Oncogene · doi:10.1038/sj.onc.1207521 · Cited by 1,384 · cited 1×
“…L O F C E L L B IO L O G Y © The Rockefeller University Press $8.00 The Journal of Cell Biology, Vol. 171, No. 1, October 10, 2005 87–98 http://www.jcb.org/cgi/doi/10.1083/jcb.200505082 JCB: ARTICLE JCB 87 Macroautophagy—a novel -amyloid peptide-generating pathway activated in Alzheimer’s disease”
InfluentialTor, a Phosphatidylinositol Kinase Homologue, Controls Autophagy in Yeast
Noda, T., & Ohsumi, Y. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.7.3963 · Cited by 1,309 · cited 1×
“, 2000; Kadowaki and Kanazawa, 2003) by treating cells with rapamycin, which is a specific inhibitor of mTOR phosphorylation and an inducer of macroautophagy (Noda and Ohsumi, 1998), or by depriving them of Leu and/or His (Kanazawa et al.”
BackgroundBillings, L. M., Oddo, S., Green, K. N., McGaugh, J. L., & LaFerla, F. M. (2005) · Neuron · doi:10.1016/j.neuron.2005.01.040 · Cited by 1,294
Autophagy Genes Are Essential for Dauer Development and Life-Span Extension in C. elegans
Meléndez, A., Tallóczy, Z., Seaman, M., Eskelinen, E.-L., Hall, D. H., & Levine, B. (2003) · Science · doi:10.1126/science.1087782 · Cited by 1,270
Petiot, A., Ogier-Denis, E., Blommaart, E. F. C., Meijer, A. J., & Codogno, P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.2.992 · Cited by 1,164 · cited 4×
“This sequestration process is controlled by the mammalian target of rapamycin (mTOR) kinase pathway, which is regulated by insulin via the PI3 kinase– Akt (protein kinase B) pathway and by specific amino acids (e.g., Leu or His) via AMP kinase (Petiot et al., 2000).”
BackgroundResultInfluentialRole of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells
Kanzawa, T., Germano, I. M., Komata, T., Ito, H., Kondo, Y., & Kondo, S. (2004) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401359 · Cited by 986 · cited 2×
“stress, exposure to toxins (Kanzawa et al., 2004), or dysfunc-”
BackgroundReconstitution of γ-secretase activity
Edbauer, D., Winkler, E., Regula, J. T., Pesold, B., Steiner, H., & Haass, C. (2003) · Nature Cell Biology · doi:10.1038/ncb960 · Cited by 882 · cited 2×
“Both -site APP cleaving enzyme and -secretase, which is a protein complex containing presenilin (PS), nicastrin, PEN2, and Aph-1 (Edbauer et al., 2003), reside in one or more compartments of the central vacuolar apparatus, which includes the ER–Golgi, plasma membrane, endosomes, and lysosomes…”
BackgroundSubversion of Cellular Autophagosomal Machinery by RNA Viruses
Jackson, W. T., Giddings, T. H., Taylor, M. P., Mulinyawe, S., Rabinovitch, M., Kopito, R. R., & Kirkegaard, K. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030156 · Cited by 818 · cited 2×
“, 2005), or from the direct fusion of AVs with the plasma membrane (Jackson et al., 2005).”
BackgroundStudies on the mechanisms of autophagy: formation of the autophagic vacuole.
Dunn, W. A. (1990) · The Journal of cell biology · doi:10.1083/jcb.110.6.1923 · Cited by 787 · cited 1×
“Inducing or inhibiting macroautophagy in neuronal and nonneuronal cells by modulating mammalian target of rapamycin kinase elicits parallel changes in AV proliferation and A production.”
BackgroundBrunk, U. T., & Terman, A. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.02869.x · Cited by 726 · cited 2×
“, 2005), probably by eliminating damaged mitochondria (Brunk and Terman, 2002), and is reCorrespondence to Ralph A.”
BackgroundMonodansylcadaverine (MDC) is a specific in vivo marker for autophagic vacuoles.
Biederbick, A., Kern, H., & Elsässer, H. (1995) · PubMed · Cited by 706
Takahashi, R. H., Milner, T. A., Li, F., Nam, E. E., Edgar, M. A., Yamaguchi, H., Beal, M. F., Xu, H., Greengard, P., & Gouras, G. K. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64463-x · Cited by 706 · cited 1×
“Previous studies have identified intracellular A accumulation in endosomes (Cataldo et al., 2004a) and multivesicular bodies (Takahashi et al., 2002) in AD and Down syndrome (Gyure et al., 2001).”
BackgroundAge-related decline in chaperone-mediated autophagy
Cuervo, A. M., & Dice, J. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002102200 · Cited by 665 · cited 1×
“In addition, several risk factors for AD, including aging (Cuervo and Dice, 2000) and PS mutations (unpublished data), impair AV maturation to lysosomes.”
BackgroundSelf-citationThe autophagosomal–lysosomal compartment in programmed cell death
Bursch, W. (2001) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400852 · Cited by 616 · cited 2×
“…development (Clarke, 1990), response to ER stress, exposure to toxins (Kanzawa et al., 2004), or dysfunction of the autophagic pathway in pathological states mediate a caspase-independent form of cell death that shares certain features with apoptosis (Bursch, 2001; Gozuacik and Kimchi, 2004).”
BackgroundInfluentialRegulation and role of autophagy in mammalian cells
Meijer, A. J., & Codogno, P. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.02.002 · Cited by 615 · cited 1×
“Autophagosomes mature to single membrane autophagolysosomes (Dunn, 1990b) by fusing with lysosomes or other mature AVs, whereupon they acidify and acquire proteolytic enzymes (Meijer and Codogno, 2004).”
BackgroundMattson, M. P., Goodman, Y., Luo, H., Fu, W., & Furukawa, K. (1997) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19970915)49:6<681::aid-jnr3>3.0.co;2-3 · Cited by 567
Autophagy and Its Possible Roles in Nervous System Diseases, Damage and Repair
Rubinsztein, D. C., DiFiglia, M., Heintz, N., Nixon, R. A., Qin, Z.-H., Ravikumar, B., Stefanis, L., & Tolkovsky, A. (2005) · Autophagy · doi:10.4161/auto.1.1.1513 · Cited by 423 · cited 1×
“As a system that is induced by nutritional stress or cell injury, macroautophagy may be activated in pathologic states (Rubinsztein et al., 2005).”
BackgroundSelf-citationMaking the diagnosis of Alzheimer's disease. A primer for practicing pathologists.
Mirra, S. S., Hart, M. N., & Terry, R. D. (1993) · PubMed · Cited by 415
Cataldo, A. M., Petanceska, S., Terio, N. B., Peterhoff, C. M., Durham, R., Mercken, M., Mehta, P. D., Buxbaum, J., Haroutunian, V., & Nixon, R. A. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.02.027 · Cited by 363 · cited 3×
“A is believed to be generated at several sites within neurons, including endosomes, Golgi, and ER (Cataldo et al., 2004a), and this multiplicity of APP processing routes would account for our observations that considerable A is still secreted from L/APP, SH-SY5Y, and N2a cells when macroautophagy…”
BackgroundSelf-citationStudies on the mechanisms of autophagy: maturation of the autophagic vacuole.
Dunn, W. A. (1990) · The Journal of cell biology · doi:10.1083/jcb.110.6.1935 · Cited by 362 · cited 1×
“…L O F C E L L B IO L O G Y © The Rockefeller University Press $8.00 The Journal of Cell Biology, Vol. 171, No. 1, October 10, 2005 87–98 http://www.jcb.org/cgi/doi/10.1083/jcb.200505082 JCB: ARTICLE JCB 87 Macroautophagy—a novel -amyloid peptide-generating pathway activated in Alzheimer’s disease”
InfluentialInduction of autophagy by amino-acid deprivation in perfused rat liver
MORTIMORE, G. E., & SCHWORER, C. M. (1977) · Nature · doi:10.1038/270174a0 · Cited by 341 · cited 2×
“Its activation reduces the size of cells, thereby decreasing their metabolic burden while generating new substrates for energy and cellular remodeling (Mortimore and Schworer, 1977; Seglen et al., 1986).”
BackgroundThe Endosomal-Lysosomal System of Neurons in Alzheimer's Disease Pathogenesis: A Review
Nixon, R. A., Cataldo, A. M., & Mathews, P. M. (2000) · Neurochemical Research · doi:10.1023/a:1007675508413 · Cited by 318 · cited 2×
“Despite the importance of the macroautophagy pathway in cell survival and its connections to other protein-trafficking pathways that are implicated in Alzheimer’s disease (AD; Nixon et al., 2000), the involvement of macroautophagy in AD has received limited attention.”
BackgroundSelf-citationPasternak, S. H., Bagshaw, R. D., Guiral, M., Zhang, S., Ackerley, C. A., Pak, B. J., Callahan, J. W., & Mahuran, D. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304009200 · Cited by 316 · cited 3×
“…which is a protein complex containing presenilin (PS), nicastrin, PEN2, and Aph-1 (Edbauer et al., 2003), reside in one or more compartments of the central vacuolar apparatus, which includes the ER–Golgi, plasma membrane, endosomes, and lysosomes (Cupers et al., 2001; Pasternak et al., 2003).”
BackgroundResultInfluentialVassar, R., & Citron, M. (2000) · Neuron · doi:10.1016/s0896-6273(00)00051-9 · Cited by 299
Hollenbeck, P. J. (1993) · The Journal of cell biology · doi:10.1083/jcb.121.2.305 · Cited by 294 · cited 1×
“During normal neurite outgrowth or regeneration, immature AVs move retrogradely and fuse with lysosomes in the neurite or are more likely near or within the cell body (Hollenbeck, 1993).”
BackgroundNewell, K. L., Hyman, B. T., Growdon, J. H., & Hedley-Whyte, E. T. (1999) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199911000-00004 · Cited by 289 · cited 4×
“Using the Consortium to Establish a Registry for AD and Reagan guidelines (Mirra et al., 1991; Newell et al., 1999), Braak staging (Braak and Braak, 1991), and the criteria proposed by Mirra et al.”
BackgroundMethodInfluentialPrelysosomal convergence of autophagic and endocytic pathways
Gordon, P. B., & Seglen, P. O. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(88)90556-6 · Cited by 281 · cited 1×
“In addition, endocytosed constituents can also enter the autophagic pathway when late endosomes fuse with autophagosomes to generate an amphisome and may be retained in the cell without complete digestion of the compartment’s contents (Gordon and Seglen, 1988).”
BackgroundYu, W. H., Kumar, A., Peterhoff, C., Shapiro Kulnane, L., Uchiyama, Y., Lamb, B. T., Cuervo, A. M., & Nixon, R. A. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.05.010 · Cited by 279
Self-citationIntraneuronal Aβ-Amyloid Precedes Development of Amyloid Plaques in Down Syndrome
Gyure, K. A., Durham, R., Stewart, W. F., Smialek, J. E., & Troncoso, J. C. (2001) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2001-125-0489-iaapdo · Cited by 248
Grbovic, O. M., Mathews, P. M., Jiang, Y., Schmidt, S. D., Dinakar, R., Summers-Terio, N. B., Ceresa, B. P., Nixon, R. A., & Cataldo, A. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304122200 · Cited by 236 · cited 1×
“Immunofluorescence microscopy, sandwich ELISA for APP and its metabolites, CTF, A 40, A 42, and Western blot analyses on cells were performed as previously described (Mathews et al., 2002; Grbovic et al., 2003).”
MethodSelf-citationKanazawa, T., Taneike, I., Akaishi, R., Yoshizawa, F., Furuya, N., Fujimura, S., & Kadowaki, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306337200 · Cited by 208 · cited 2×
“…et al., 2000; Kadowaki and Kanazawa, 2003) by treating cells with rapamycin, which is a specific inhibitor of mTOR phosphorylation and an inducer of macroautophagy (Noda and Ohsumi, 1998), or by depriving them of Leu and/or His (Kanazawa et al., 2003) substantially increased the number of AVs (Fig.”
BackgroundShigemitsu, K., Tsujishita, Y., Hara, K., Nanahoshi, M., Avruch, J., & Yonezawa, K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.2.1058 · Cited by 200 · cited 1×
“4 D) and reduced levels of phosphorylated mTOR but not total mTOR relative to the values measured in untreated or 3-methyladenine (3MA)–treated cells as expected (Shigemitsu et al., 1999).”
BackgroundAsanuma, K., Tanida, I., Shirato, I., Ueno, T., Takahara, H., Nishitani, T., Kominami, E., & Tomino, Y. (2003) · The FASEB Journal · doi:10.1096/fj.02-0580fje · Cited by 186 · cited 2×
“…the direction of multiple proteins, including microtubule-associated light chain 3-II (LC3-II), that, together, orchestrate membrane elongation and sequestration of a region of cytoplasm and organelles into a double membrane–limited autophagic vacuole (AV) or autophagosome (Asanuma et al., 2003).”
BackgroundInduction of Autophagy Causes Dramatic Changes in the Subcellular Distribution of GFP‐Rab24
Munafó, D. B., & Colombo, M. I. (2002) · Traffic · doi:10.1034/j.1600-0854.2002.30704.x · Cited by 182 · cited 1×
“roautophagy (Fig. 7 B; Munafo and Colombo, 2002).”
Fine structural localization of acid phosphatase in senile plaques in Alzheimer's presenile dementia
Suzuki, K., & Terry, R. D. (1967) · Acta Neuropathologica · doi:10.1007/bf00688828 · Cited by 169 · cited 1×
“Lysosome-related multilamellar and dense bodies have been described previously in neurological disease states (Suzuki and Terry, 1967; Masliah et al., 1993) and, in part, represent late stages of macroautophagic activity and lysosomal digestion (Nixon et al.”
BackgroundAmino Acids as Regulators of Proteolysis
Kadowaki, M., & Kanazawa, T. (2003) · The Journal of Nutrition · doi:10.1093/jn/133.6.2052s · Cited by 167 · cited 3×
“4 A, bottom, SH-SY5Y; N2a, not depicted) cell models, inducing macroautophagy via the mTOR kinase pathway (Seglen et al., 1996; Petiot et al., 2000; Kadowaki and Kanazawa, 2003) by treating cells with rapamycin, which is a specific inhibitor of mTOR phosphorylation and an inducer of macroautophagy (Noda and Ohsumi, 19…”
BackgroundResultPresenilin-1 and Presenilin-2 Exhibit Distinct yet Overlapping γ-Secretase Activities
Lai, M.-T., Chen, E., Crouthamel, M.-C., DiMuzio-Mower, J., Xu, M., Huang, Q., Price, E., Register, R. B., Shi, X.-P., Donoviel, D. B., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300974200 · Cited by 167 · cited 1×
“…PS dependent To confirm that fluorogenic substrate cleavage was PS1 specific, we assayed its activity in AVs that were isolated from JCB • VOLUME 171 • NUMBER 1 • 200594 PS1 PS2 knockout (PS KO) blastocysts (BD8; Lai et al., 2003) and BD8 blastocysts that were transfected with human PS1 (BD8/hPS1).”
MethodCataldo, A. M., Peterhoff, C. M., Schmidt, S. D., Terio, N. B., Duff, K., Beard, M. E., Mathews, P. M., & Nixon, R. A. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.8.821 · Cited by 166 · cited 3×
“A is believed to be generated at several sites within neurons, including endosomes, Golgi, and ER (Cataldo et al., 2004a), and this multiplicity of APP processing routes would account for our observations that considerable A is still secreted from L/APP, SH-SY5Y, and N2a cells when macroautophagy…”
BackgroundSelf-citationFibrillar β-amyloid evokes oxidative damage in a transgenic mouse model of Alzheimer’s disease
Matsuoka, Y., Picciano, M., LaFrancois, J. J., & Duff, K. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00115-4 · Cited by 166 · cited 2×
“To investigate early induction in PS1/APP mice, we also analyzed LC3-II levels in these mice at an age (8–9 wk) that precedes known neuropathology, including A deposition (“predepositing” mice; Matsuoka et al., 2001).”
BackgroundSelf-citationBendiske, J., & Bahr, B. A. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.5.451 · Cited by 165
Partial Purification and Characterization of γ-Secretase from Post-mortem Human Brain
Farmery, M. R., Tjernberg, L. O., Pursglove, S. E., Bergman, A., Winblad, B. G., & Näslund, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211992200 · Cited by 165 · cited 3×
“A fluorogenic -secretase substrate (Nma-GGVVIATVK[DNP]-rrr-NH2; Farmery et al., 2003) was added at a 10-”
BackgroundMethodSelf-citationCupers, P., Bentahir, M., Craessaerts, K., Orlans, I., Vanderstichele, H., Saftig, P., De Strooper, B., & Annaert, W. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200104045 · Cited by 158 · cited 4×
“…labeling and EM in Leu- and His-deprived L/APP cells, we observed that A and -secretase components were preferentially localized to AVs in situ and, as previously described (Cupers et al., 2001), were localized to tubulovesicular compartments corresponding morphologically to ER/ Golgi/endosomes.”
BackgroundInfluentialProtein Accumulation in Traumatic Brain Injury
Smith, D. H., Uryu, K., Saatman, K. E., Trojanowski, J. Q., & McIntosh, T. K. (2003) · NeuroMolecular Medicine · doi:10.1385/nmm:4:1-2:59 · Cited by 158 · cited 1×
“AV accumulation that is associated with any significant neuritic injury could stimulate local A production, as seen, for example, in traumatic brain injury (Smith et al., 2003).”
BackgroundIsolation of autophagic vacuoles from rat liver: morphological and biochemical characterization.
Marzella, L., Ahlberg, J., & Glaumann, H. (1982) · The Journal of Cell Biology · doi:10.1083/jcb.93.1.144 · Cited by 155 · cited 3×
“By using a protocol that was modified from Marzella et al. (1982), the cells were harvested, disrupted by nitrogen cavitation, homogenized, and separated by differential centrifugation to first produce a (low speed) pellet containing the nuclear fraction and (up to 30”
MethodInfluentialAmino acid control of autophagic sequestration and protein degradation in isolated rat hepatocytes.
Seglen, P. O., & Gordon, P. B. (1984) · The Journal of Cell Biology · doi:10.1083/jcb.99.2.435 · Cited by 150 · cited 1×
“10 nM rapamycin was used to induce macroautophagy, whereas 5 mM 3MA (Sigma-Aldrich) was used to inhibit AV formation (Seglen and Gordon, 1984).”
MethodFUERTES, G., DE LLANO, J. J. M., VILLARROYA, A., RIVETT, A. J., & KNECHT, E. (2003) · Biochemical Journal · doi:10.1042/bj20030282 · Cited by 149 · cited 1×
“For each cell line (L/APP, PS KO–BD8, or hPS1–BD8/hPS1), 500 million cells were serum deprived overnight to induce autophagic activity (Fuertes et al., 2003).”
BackgroundWegiel, J., Wang, K. C., Tarnawski, M., & Lach, B. (2000) · Acta Neuropathologica · doi:10.1007/s004010000199 · Cited by 124 · cited 2×
“Seven of these cases (aged 71–86 yr) were later found to meet the neuropathological criteria of AD (Braak and Braak, 1991; Mirra et al., 1991, 1993; Newell et al., 1999), and the remaining three specimens (aged 67–72 yr) were found to be neuropathologically normal (Wegiel et al., 2000).”
BackgroundThe neuronal endosomal-lysosomal system in Alzheimer's disease
Nixon, R. A., Mathews, P. M., & Cataldo, A. M. (2001) · Journal of Alzheimer s Disease · doi:10.3233/jad-2001-3114 · Cited by 122 · cited 1×
“Macroautophagy, as a pathway for A generation and a mediator of both cell survival and degenerative phenomena (Nixon et al., 2001), represents a new direction for investigations into the pathogenesis and possible therapy of AD.”
BackgroundSelf-citationDynamic Organization of Endocytic Pathways in Axons of Cultured Sympathetic Neurons
Overly, C. C., & Hollenbeck, P. J. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-19-06056.1996 · Cited by 121
Exosomes: A Bubble Ride for Prions?
Février, B., Vilette, D., Laude, H., & Raposo, G. (2004) · Traffic · doi:10.1111/j.1600-0854.2004.00247.x · Cited by 118 · cited 1×
“Extracellular release of some A from AVs is also possible from exosomes, which is a mechanism proposed for prion release (Fevrier et al., 2005), or from the direct fusion of AVs with the plasma membrane (Jackson et al., 2005).”
BackgroundRe-Evaluation of the Structural Organization of Neuritic Plaques in Alzheimerʼs Disease
MASLIAH, E., MALLORY, M., DEERINCK, T., DETERESA, R., LAMONT, S., MILLER, A., TERRY, R. D., CARRAGHER, B., & ELLISMAN, M. (1993) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199311000-00009 · Cited by 105
Calpain Activity Regulates the Cell Surface Distribution of Amyloid Precursor Protein
Mathews, P. M., Jiang, Y., Schmidt, S. D., Grbovic, O. M., Mercken, M. H., & Nixon, R. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205208200 · Cited by 105 · cited 4×
“The antibodies used for A ELISAs have been previously described (Mathews et al., 2002) and were a gift from Johnson and Johnson Pharmaceutical Research and Development/Janssen Pharmaceutica (Beerse, Belgium).”
BackgroundMethodInfluentialSelf-citationStructural Aspects of Autophagy
Seglen, P. O., Berg, T. O., Blankson, H., Fengsrud, M., Holen, I., & STRØMHAUG, P. E. (1996) · Advances in experimental medicine and biology · doi:10.1007/978-1-4613-0335-0_12 · Cited by 93 · cited 2×
“4 A, bottom, SH-SY5Y; N2a, not depicted) cell models, inducing macroautophagy via the mTOR kinase pathway (Seglen et al., 1996; Petiot et al., 2000; Kadowaki and Kanazawa, 2003) by treating cells with rapamycin, which is a specific inhibitor of mTOR phosphorylation and an inducer of macroautophagy (Noda and Ohsumi, 19…”
BackgroundThe Diagnosis of Alzheimer's Disease
Villareal, D. T., & Morris, J. C. (1999) · Journal of Alzheimer s Disease · doi:10.3233/jad-1999-14-506 · Cited by 90
Culvenor, J. G., Maher, F., Evin, G. M., Malchiodi‐Albedi, F., Cappai, R., Underwood, J. R., Davis, J. B., Karran, E. H., Roberts, G. W., Beyreuther, K. T., et al. (1997) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19970915)49:6<719::aid-jnr6>3.0.co;2-a · Cited by 84 · cited 1×
“3 D, arrowheads), which is consistent with the expected contribution of PS1-rich smooth ER to AV formation (Culvenor et al., 1997).”
BackgroundCataldo, A., Barnett, J. L., Mann, D. M. A., & Nixon, R. A. (1996) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199606000-00004 · Cited by 74 · cited 2×
“…Cruz Biotechnology, Inc.) and a polyclonal EEA1 (gift from S. Corvero, University of Massachusetts, Worcester, MA) for endosomes, a mAb clone p58K-9 for Golgi (SigmaAldrich), a pAb calnexin (StressGen Biotechnologies) for ER, and an anticathepsin D polyclonal for lysosomes (Cataldo et al., 1996).”
BackgroundSelf-citationMembrane traffic to and from lysosomes.
Luzio, J. P., Pryor, P. R., Gray, S. R., Gratian, M. J., Piper, R. C., & Bright, N. A. (2005) · Biochemical Society Symposia · doi:10.1042/bss0720077 · Cited by 61 · cited 1×
“95 between the macroautophagy and endosomal systems also provides one possible avenue for A that is generated during macroautophagy to be released from cells, because late endosomes also communicate with endocytic recycling compartments (for review see Luzio et al., 2005).”
BackgroundAskanas, V., Engel, W. K., Yang, C., Alvarez, R. B., Lee, V. M.-Y., & Wısnıewskı, T. (1998) · Europe PMC (PubMed Central) · Cited by 59
Leuba, G., Wernli, G., Vernay, A., Kraftsik, R., Mohajeri, M. H., & Saini, K. (2005) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000083496 · Cited by 54 · cited 2×
“Moreover, APP, -site APP cleaving enzyme, and PS1 are reported to be abundant within neuritic plaques (Leuba et al., 2005), raising the possibility that these components are localized in AVs.”
BackgroundUse of [3H]raffinose as a specific probe of autophagic sequestration
Seglen, P. O., Gordon, P. B., Tolleshaug, H., & HØYVIK, H. (1986) · Experimental Cell Research · doi:10.1016/0014-4827(86)90446-5 · Cited by 47
Petanceska, S. S., Seeger, M., Checler, F., & Gandy, S. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741878.x · Cited by 32
(2018) · Digital Commons@Becker (Washington University School of Medicine) · doi:10.1371/journal
Research works printed but not linked: 5
- 1998, Am. J. Pathol., 152, 889
- 1995, Eur. J. Cell Biol., 66, 3
- 1990, Anat. Embryol. (Berl.)., 181, 195
- 2003, J Biol Chem., 279, 8452
- 1993, Arch. Pathol. Lab. Med., 117, 132
Cited by
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
Autophagy in the Pathogenesis of Disease
Levine, B., & Kroemer, G. (2008) · Cell · doi:10.1016/j.cell.2007.12.018 · Cited by 7,069
Autophagy fights disease through cellular self-digestion
Mizushima, N., Levine, B., Cuervo, A. M., & Klionsky, D. J. (2008) · Nature · doi:10.1038/nature06639 · Cited by 6,452
Self-citationAutophagy: process and function
Mizushima, N. (2007) · Genes & Development · doi:10.1101/gad.1599207 · Cited by 3,967
Loss of autophagy in the central nervous system causes neurodegeneration in mice
Komatsu, M., Waguri, S., Chiba, T., Murata, S., Iwata, J.-I., Tanida, I., Ueno, T., Koike, M., Uchiyama, Y., Kominami, E., et al. (2006) · Nature · doi:10.1038/nature04723 · Cited by 3,500
Self-citation
Metadata
- Authors
- Yu, W. H., Cuervo, A. M., Kumar, A., Peterhoff, C. M., Schmidt, S. D., Lee, J.-H., Mohan, P. S., Mercken, M., Farmery, M. R., Tjernberg, L. O., Jiang, Y., Duff, K., Uchiyama, Y., Näslund, J., Mathews, P. M., Cataldo, A. M., & Nixon, R. A.
- Affiliations
- Nathan Kline Institute for Psychiatric Research (US)
- 4Marion Bessin Liver Research Center, Albert Einstein College of Medicine, Bronx, NY 10461
- Janssen (Belgium) (BE)
- Karolinska Institutet (SE)
- The University of Osaka (JP)
- 6Neurotec, Karolinska Institutet, Novum-KASPAC, SE-141 57 Huddinge, Sweden
- McLean Hospital (US)
- ORCID
- Venue
- The Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2005-10-03
- Volume
- 171
- Issue
- 1
- Pages
- 87-98
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- PMC
- PMC2171227
- OpenAlex
- W2167115031
- Cited by
- 967
- References
- 77
- Citations by year
- 2026: 22 · 2025: 36 · 2024: 38 · 2023: 34 · 2022: 52 · 2021: 43 · 2020: 51 · 2019: 49 · 2018: 47 · 2017: 47 · 2016: 67 · 2015: 68 · 2014: 48 · 2013: 55 · 2012: 68
- FWCI
- 17.98
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Cell Biology (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (R01AG021904, R37AG021904, AG17617-05, AG-021904, P01AG017617)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- macroautophagy, amyloid-beta, Alzheimer's disease, autophagosomes, lysosome maturation, presenilin 1, APP processing, gamma-secretase, nicastrin, mTOR kinase, neuronal survival, beta-amyloidosis
- MeSH terms
- Adult, Aged, Aged, 80 and over, Alzheimer Disease, Animals, Autophagy, Brain, Female, Humans, Male, Membrane Proteins, Middle Aged, Models, Molecular, Mutation, Endopeptidases, Vacuoles, Signal Transduction, Amyloid beta-Peptides, Microscopy, Immunoelectron, Aspartic Acid Endopeptidases, Amyloid beta-Protein Precursor, Mice, Presenilin-1, Amyloid Precursor Protein Secretases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.